CUOMO, ONOFRIO
 Distribuzione geografica
Continente #
NA - Nord America 76
EU - Europa 58
AS - Asia 21
Totale 155
Nazione #
US - Stati Uniti d'America 76
IT - Italia 41
SG - Singapore 17
GB - Regno Unito 5
NL - Olanda 5
IN - India 2
RU - Federazione Russa 2
SE - Svezia 2
CN - Cina 1
DE - Germania 1
FI - Finlandia 1
FR - Francia 1
IR - Iran 1
Totale 155
Città #
Chandler 16
Chicago 9
London 5
Singapore 5
Ashburn 4
Ercolano 4
Santa Clara 4
Lawrence 3
Paola 3
Princeton 3
Rome 3
Delhi 2
Gesuiti 2
San Nicola Manfredi 2
Boardman 1
Cosenza 1
Helsinki 1
Jinhua 1
Milan 1
Naples 1
Nuremberg 1
Palermo 1
St Petersburg 1
Wilmington 1
Totale 75
Nome #
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 52
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 51
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report 32
The antiepileptic drug levetiracetam suppresses non-convulsive seizure activity and reduces ischemic brain damage in rats subjected to permanent middle cerebral artery occlusion 24
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 9
Totale 168
Categoria #
all - tutte 1.618
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.618


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 1 0 0 0 0 0 0 0 0
2021/202219 0 0 0 1 1 0 1 1 9 6 0 0
2022/202346 6 6 1 2 7 4 0 3 9 3 3 2
2023/202443 19 4 4 1 2 7 0 0 0 0 3 3
2024/202559 7 3 1 5 8 14 6 3 10 2 0 0
Totale 168